Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05723497 · ClinicalTrials.gov registry record · NA
Elderberries and Obesity
A NA study, sponsored by Washington State University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05723497: Completed NA study, sponsored by Washington State University.
NCT05723497 is a NA study that has completed, run by Washington State University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05723497, a NA study, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Previous studies in humans indicate that anthocyanin-rich berries can positively alter fat oxidation and insulin sensitivity. This study will determine if this is also true with elderberries, which are a more concentrated source of anthocyanins compared to other commonly consumed berries.
Primary Outcome
Participants will be monitored by a metabolic cart at rest and while walking
Interventions
- OTHER Placebo beverage
- OTHER Elderberry juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-07-27 |
| Est. Completion | 2022-09-02 |
| Phase | NA |
What the finished NCT05723497 record still lists
NCT05723497 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo beverage is the first listed.
NCT05723497 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05723497 about?
NCT05723497 is a clinical study titled "Elderberries and Obesity". Previous studies in humans indicate that anthocyanin-rich berries can positively alter fat oxidation and insulin sensitivity. This study will determine if this is also true with elderberries, which are a more concentrated source of anthocyanins compared to other commonly consumed berries.
What is the current status of trial NCT05723497?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-07-27. Estimated completion is 2022-09-02.
What interventions are being tested in trial NCT05723497?
The interventions under investigation include: Placebo beverage (OTHER), Elderberry juice (OTHER).
Who is sponsoring clinical trial NCT05723497?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05723497's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI